Brief: Pila Pharma Q4 EBIT Loss Widens To SEK 3.1 Mln
18/02/2022 07:18
Feb 18 (Reuters) - Pila Pharma AB PILA.ST :
* PILA PHARMA PUBLISHES YEAR-END REPORT JANUARY 1 - DECEMBER
31,
2021
* Q4 REVENUE WAS 719 KSEK (0)
* Q4 OPERATING LOSS (EBIT) WAS - 3 080 KSEK (-1 621)
Source text for Eikon: ID:nBQN2p0D3z
Further company coverage: PILA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))